ABOUT NANOLOGICA

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers.

Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity.

The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments.

The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.

NLAB Saga®
A NEW GENERATION SILICA FOR PREPARATIVE CHROMATOGRAPHY

NLAB Saga® is a perfectly spherical, fully porous silica with superior mechanical stability and exceptional
chemical stability at high and low pH, making it an
optimum choice for large scale purification of peptides.

News

Teckning av units i pågående företrädesemission

Teckning av units kan ske via anmälningssedel eller länk nedan. Anmälningssedel units Nanologica AB https://app.verified.eu/web/bergs-securities/?company=Nanologica Teckningsperiod 30 september – 14 oktober 2024   Mer information om företrädesemissionen finns här.

Read more »

Listen to our team talk about Nlab Saga®

Play Video about Katarina Alenäs – SVP Chromatography

Interview with Katarina Alenäs,
SVP Chromatography

Play Video

Interview with Olga Krivosheeva, Ph.D.
Application Project Manager 

Play Video

Interview with Chunfang Zhou, Ph.D.
Sales Manager China

Nanologica is a public company listed for trade on Nasdaq Stockholm Main Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.

Presentation of Nanologica

For more videos presentations of the company and of interim reports, please refer to Investor Relations.

Company presentation made by CEO Andreas Bhagwani in June, 2023.

Investor Pitch Deck September 2023.

Please contact us at ir@nanologica.com for more information.